Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients.
J Neurol. 2022 Oct;269(10):5596-5605. doi: 10.1007/s00415-022-11227-3. Epub 2022 Jun 27.
J Neurol. 2022.
PMID: 35759013
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients.
Sferruzza G, Clarelli F, Mascia E, Ferrè L, Ottoboni L, Sorosina M, Santoro S, Moiola L, Martinelli V, Comi G, Martinelli Boneschi F, Filippi M, Provero P, Esposito F.
Sferruzza G, et al.
Mol Neurobiol. 2021 Oct;58(10):4816-4827. doi: 10.1007/s12035-021-02465-z. Epub 2021 Jun 28.
Mol Neurobiol. 2021.
PMID: 34181235
Item in Clipboard
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.
Ferre' L, et al.
Neurol Sci. 2018 Aug;39(8):1467-1470. doi: 10.1007/s10072-018-3440-0. Epub 2018 May 13.
Neurol Sci. 2018.
PMID: 29756179
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.